Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
MedTech
FDA clears Clairity's 5-year breast cancer risk prediction tool
The FDA’s de novo clearance paves the way for Clairity to launch the risk prediction platform with leading health systems through 2025.
Heather Landi
Jun 5, 2025 1:00pm
Smiths Medical recalls infusion pumps over 3 safety risks
Jun 5, 2025 9:46am
ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma
May 31, 2025 8:00am
Stealth CEO questions FDA rejection of rare disease drug
May 29, 2025 2:27pm
Daiichi, Merck pull HER3-DXd filing at FDA
May 29, 2025 9:40am
Stealth hit by FDA rejection to twice-delayed filing
May 29, 2025 7:46am
